As part of a long term goal to understand the regulation of cell behavior by the extracellular matrix, this research focuses on heparan sulfate proteoglycans at the cell surface. These proteoglycans are at the surfaces of all adherent cells and undergo changes in expression and glycosylation during development, neoplasia, local invasion and metastasis. One integral membrane proteoglycan, syndecan, binds a diverse set of ligands, links the extracellular matrix to the cytoskeleton, varies in its location at the cell surface and in the number and size of its glycosaminoglycan chains depending on cell type and organization, and has a unique core protein sequence which bears heparan sulfate chains containing heparin-like domains. Recent results lead to the working hypothesis that syndecan and related molecules appear to have multiple functions because they can bind a variety of biological effector molecules and can act in partnership or combination with other cell surface receptors to alter cellular behavior.
The specific aims of this research are to: (i) define the interaction of various extracellular ligands with syndecan by assessing their binding to the structurally polymorphic forms of syndecan, (ii) test whether syndecan acts in combination with other receptors by comparing the responses of syndecan-deficient and syndecan-replete cells to various ligands, (iii) demonstrate the function of various core protein domains of syndecan by expressing native and mutant syndecans on cells that do not express cell surface syndecan, and (iv) determine whether syndecan is a member of a gene family by preparing antibody and cDNA probes based on syndecan sequences that are conserved between species, and by purifying and identifying candidate syndecan-like core proteins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA028735-14
Application #
2087781
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1980-06-01
Project End
1996-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Long, Olivia S; Gosai, Sager J; Kwak, Joon Hyeok et al. (2011) Using Caenorhabditis elegans to study serpinopathies. Methods Enzymol 499:259-81
Reizes, Ofer; Goldberger, Olga; Smith, April C et al. (2006) Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: a proposed mechanism for stabilization of extracellular lipoprotein lipase. Biochemistry 45:5703-11
Gotte, Martin; Bernfield, Merton; Joussen, Antonia M (2005) Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps. Curr Eye Res 30:417-22
Wang, Zihua; Gotte, Martin; Bernfield, Merton et al. (2005) Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. Biochemistry 44:12355-61
Elenius, Varpu; Gotte, Martin; Reizes, Ofer et al. (2004) Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J Biol Chem 279:41928-35
Gotte, Martin (2003) Syndecans in inflammation. FASEB J 17:575-91
Gotte, Martin; Joussen, Antonia M; Klein, Christoph et al. (2002) Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest Ophthalmol Vis Sci 43:1135-41
Park, P W; Pier, G B; Preston, M J et al. (2000) Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem 275:3057-64
Fitzgerald, M L; Wang, Z; Park, P W et al. (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148:811-24
Park, P W; Reizes, O; Bernfield, M (2000) Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem 275:29923-6

Showing the most recent 10 out of 45 publications